CHANGING TOMORROW
LIVE

Serial Number

85832274

Owner

ASTELLAS PHARMA INC.

Attorney

Christopher Bolinger

Filing Date

Jan 25, 2013

Add to watchlist:

No watchlists yet
View on USPTO

CHANGING TOMORROW Trademark

Serial Number: 85832274 • Registration: 4442676

CHANGING TOMORROW is a trademark filed by ASTELLAS PHARMA INC. on January 25, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ASTELLAS PHARMA INC. (257 trademarks)

3-11 NIHONBASHI-HONCHO 2-CHOME, CHUO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

January 25, 2013

Registration Date

December 3, 2013

Published for Opposition

September 17, 2013

Goods & Services

[ Educational and instruction services, namely, providing classes, seminars, workshop relating to pharmaceuticals, health, medical treatments and health care; educational services, namely, arranging, conducting and organization of seminars, forums, symposiums, academic conferences and lecture meetings in the fields of pharmaceuticals, health, medical treatments and health care ]

[ Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for medical purposes for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides ]

[ Printed pamphlets, brochures, manuals, books, booklets, leaflets, flyers, informational sheets and newsletters, adhesive backed stickers, and kits comprising one or more of the foregoing materials in the field of pharmaceuticals ]

[ Offering a subsidy to medical services, namely, providing financial assistance to disadvantaged persons for health care; investigation for offering a subsidy, namely, providing information about the provision of financial assistance to disadvantaged persons for health care; ] development and running projects for offering a subsidy, namely, administering monetary charitable contributions for disadvantaged persons for healthcare; charitable fund raising

[ Providing information on pharmaceuticals sales and other commodity sales ]

Providing information relating to medical treatments and health care; providing medical information relating to pharmaceuticals: providing medical information

Testing, inspection or research of pharmaceuticals; providing information relating to testing, inspection or research of pharmaceuticals; providing information relating to testing, inspection or research in the fields of medicine, pharmaceuticals, medical treatments and health care

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 10, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 10, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 10, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 10, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 10, 2023 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 10, 2023 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 10, 2023 89AG
TEAS SECTION 8 & 9 RECEIVED
Aug 9, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 3, 2022 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 3, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 3, 2022 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 28, 2020 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 28, 2020 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 28, 2020 APRE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2019 REAP
TEAS SECTION 8 & 15 RECEIVED
Dec 3, 2019 E815
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2013 R.PR
PUBLISHED FOR OPPOSITION
Sep 17, 2013 PUBO
NOTICE OF PUBLICATION
Aug 28, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 15, 2013 PREV
ASSIGNED TO LIE
Aug 15, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2013 TROA
NON-FINAL ACTION MAILED
Feb 13, 2013 CNRT
NON-FINAL ACTION WRITTEN
Feb 13, 2013 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 31, 2013 NWOS
NEW APPLICATION ENTERED
Jan 29, 2013 NWAP